We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cumulative Radiation Exposure Shows Increased Cancer Risk for ER Patients

By MedImaging staff writers
Posted on 23 Jun 2008
According to a new study, emergency room (ER) patients may be receiving radiation doses estimated on the basis of medical diagnostic imaging studies, such as computed tomography (CT) scans, which can be detrimental to their long-term health prospects, putting them at an increased risk of developing cancer. More...
Up to now, ER physicians have not been made aware of the cumulative amount of radiation that their patients receive. In fact, they currently have no way to know or estimate any given patient's cumulative dose. A new study hopes to quantify and additionally examine these concerns.

Led by Timothy B. Bullard, M.D., M.B.A., from the Orlando Regional Medical Center (ORMC; FL, USA), the cross-sectional study evaluated the amount of ionizing radiation that a random selection of patients received over a five-year period at ORMC and Washington Hospital Center (Washington, DC, USA). The study is the first to estimate the total cumulative radiation dosage delivered to a population from multiple diagnostic imaging modalities during a defined period of time.

Patients had a median cumulative estimated effective radiation dose of 45 milliseiverts (mSv), with CT scans and nuclear medicine studies contributing the most radiation. Of the sample population, 12% was estimated to have received 100 or more mSv of radiation, a value that exceeds the accepted threshold of safety for exposure to low-level ionizing radiation. If study patients are representative of the general emergency department population, then a considerable number of individuals may be placed at increased risk of developing cancer over their lifetime from diagnostic imaging studies as a result of these exposures.

"Our research hopefully will affect the habits of physicians who routinely order medical imaging diagnostic studies in their practices,” said Dr. Bullard. "We also hope that our research will further promote the need for electronic medical records with portability and encourage the development of an individual patient cumulative exposure estimate tool.”

The study was presented at the 2008 Society of Academic Emergency Medicine (SAEM) annual meeting in Washington, DC, USA, on May 29, 2008.


Related Links:
Orlando Regional Medical Center
Washington Hospital Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.